Clinics in Alaska
By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed. Last verified
What Alaska law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and listings with their verification status.
Alaska at a glance
- Pharmacy regulator
- Alaska Board of Pharmacy
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async unclear
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Clinics serving Alaska
No verified clinics serving Alaska are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.
Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.
Run a pharmacy, clinic, or telehealth service? Apply for a listing.
Peptide access rules in Alaska
Yes. An Alaska resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from an Alaska-licensed provider, including by telehealth under AS 08.64.364 (physicians) and the 2022 cross-profession telehealth statute AS 08.02.130, and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy holding an Alaska pharmacy license. Since November 2023 every out-of-state pharmacy shipping into Alaska must hold a full Alaska pharmacy license under AS 08.80.157 rather than the old nonresident registration, and telehealth businesses must be on the state Telemedicine Business Registry. A physician may not prescribe to a new patient in response to an internet questionnaire or email, and Alaska law does not settle whether a prescription can follow an evaluation with no live visit. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10]
Compounded GLP-1 access in Alaska
Because Alaska now requires a full pharmacy license for any out-of-state pharmacy, Alaska patients using telehealth GLP-1 programs should confirm the dispensing pharmacy appears in the Division's professional license search as an Alaska-licensed pharmacy. [1] [2] [11]
Research use only sellers in Alaska
Any entity distributing prescription drugs into Alaska must be licensed by the Board of Pharmacy under AS 08.80.157, and peptides sold "for research use only" but marketed for human injection are unapproved new drugs under 21 U.S.C. 331 regardless of labeling. These products are not dispensed by a pharmacist, are not covered by Alaska's Telemedicine Business Registry protections, and carry no state consumer safeguards. [2] [12]
How to check a clinic in Alaska
- Confirm the prescribing clinician's license with the Alaska medical or nursing board.
- Ask which pharmacy compounds or dispenses the peptide and check it in the Alaska Board of Pharmacy license lookup. [1] [2] [3] [4] [10]
- Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Alaska. [2] [12]
Common questions in Alaska
Can I get a GLP-1 prescription in Alaska through telehealth without a physical exam?
Yes. AS 08.64.364 protects an Alaska-licensed physician or physician assistant from Board discipline for prescribing a non-controlled drug without a physical examination if follow-up care is available and the prescriber asks for your consent to send the records to your primary care provider. AS 08.02.130 lets Alaska-licensed providers treat patients by telehealth without a first in-person visit. Semaglutide and tirzepatide are not controlled substances. AS 08.64.364 also bars prescribing to a new patient in response to an internet questionnaire or email. Alaska law does not settle whether an evaluation with no live visit is enough, because the two practice standards the Board has adopted point in different directions. [5] [7] [8]
Does an out-of-state telehealth clinic need an Alaska license to treat me?
Generally yes. The provider must hold an Alaska license from the relevant board, and the business must be listed on Alaska's Telemedicine Business Registry. AS 08.02.130(b) lets a physician licensed in another state provide telehealth only in narrow cases: follow-up care for an established patient the physician has seen in person, a referred visit about a life-threatening condition, and ongoing care for a life-threatening condition. [6] [7]
Sources
- [1]Alaska Board of Pharmacy (Division of Corporations, Business and Professional Licensing)
- [2]Alaska Board of Pharmacy: statutes and regulations (AS 08.80 and 12 AAC 52, including the 2023 pharmacy licensing changes)
- [3]12 AAC 52.440, Guidelines relating to compounding practices
- [4]Alaska Legislature, Alaska Administrative Code: 12 AAC 52.430 (sterile pharmaceuticals) and 12 AAC 52.440 (compounding practices), accessed 2026-09-22
- [5]Alaska Statutes AS 08.64.364, Prescribing without a physical examination (telehealth), accessed 2026-09-30
- [6]Alaska Division of Corporations, Business and Professional Licensing: telehealth information and Telemedicine Business Registry (AS 08.02.130)
- [7]Alaska Statutes AS 08.02.130, Telehealth (added by HB 265, 2022; amended by SB 91, 2024), accessed 2026-09-30
- [8]12 AAC 40.943, Standards of practice for telemedicine (adopts AMA Council on Medical Service Report 7 (A-14) and the FSMB April 2014 model policy; subsection (b) repealed effective July 4, 2026), accessed 2026-09-30
- [9]Alaska Online Public Notices: State Medical Board regulations re: Telemedicine Standards of Practice (12 AAC 40.943), filed June 4, 2026, effective July 4, 2026
- [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [11]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [12]21 U.S.C. 331, Prohibited acts